Reshape Lifesciences Inc.
RSLS
Revenue
1.97M
▲21.00k▲1.08%
3 Months ChangeAssets
6.39M
▼-1.84M▼-22.33%
3 Months ChangeLiabilities
3.36M
▼-339.00k▼-9.17%
3 Months ChangeFree Cash Flow
-5.07M
▲2.32M▲31.37%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001104659-24-109401
2024-09-24
Form 8-K
ID: 0001558370-24-012969
2024-08-14
Form 8-K
ID: 0001558370-24-012263
2024-08-14
Form 10-Q
ID: 0001558370-24-012246
2024-07-09
Form 8-K
ID: 0001558370-24-009704
2024-05-20
Form 8-K
ID: 0001558370-24-008491
2024-05-15
Form 10-Q
ID: 0001558370-24-008304
2024-04-10
Form 8-K
ID: 0001558370-24-004933
2024-04-10
Form 8-K
ID: 0001558370-24-004898
2024-04-04
Form 8-K
ID: 0001558370-24-004700